Peer-reviewed veterinary case report
Use of recombinant human interferon alpha-2a in the management of a dog with epitheliotropic lymphoma.
- Journal:
- Journal of the American Animal Hospital Association
- Year:
- 2008
- Authors:
- Tzannes, Sophia et al.
- Affiliation:
- Department of Clinical Veterinary Science · United Kingdom
- Species:
- dog
Abstract
An 8-year-old, mixed-breed dog with preputial epitheliotropic lymphoma was initially treated with cyclophosphamide, vincristine, and prednisolone. A short-term partial response was followed by disease progression after 4 weeks. Recombinant human interferon alpha-2a was administered starting at week 7. The interferon therapy resulted in rapid resolution of clinical signs and a 10-week disease-free interval. The lymphoma recurred at 17 weeks and did not respond to rescue chemotherapy. Additional oral lesions were treated with localized radiotherapy followed by increased dosages of interferon. This additional interferon treatment resulted in another 12 weeks of stable disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/18762565/